SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-21-022170
Filing Date
2021-06-24
Accepted
2021-06-24 16:02:04
Documents
5
Effectiveness Date
2021-06-24

Document Format Files

Seq Description Document Type Size
1 S-8 brhc10026159_s8.htm S-8 73985
2 EXHIBIT 4.1 brhc10026159_ex4-1.htm EX-4.1 91676
3 EXHIBIT 5.1 brhc10026159_ex5-1.htm EX-5.1 6579
4 EXHIBIT 23.1 brhc10026159_ex23-1.htm EX-23.1 2220
5 image0.jpg GRAPHIC 5376
  Complete submission text file 0001140361-21-022170.txt   183279
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-257345 | Film No.: 211042860
SIC: 3841 Surgical & Medical Instruments & Apparatus